Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
-
Published:2016-05
Issue:5
Volume:150
Page:1147-1159.e5
-
ISSN:0016-5085
-
Container-title:Gastroenterology
-
language:en
-
Short-container-title:Gastroenterology
Author:
Ratziu Vlad, Harrison Stephen A., Francque SvenORCID, Bedossa Pierre, Lehert Philippe, Serfaty Lawrence, Romero-Gomez ManuelORCID, Boursier Jérôme, Abdelmalek Manal, Caldwell Steve, Drenth Joost, Anstee Quentin M., Hum Dean, Hanf Remy, Roudot Alice, Megnien Sophie, Staels Bart, Sanyal Arun, Mathurin P., Gournay J., Nguyen-Khac E., De Ledinghen V., Larrey D., Tran A., Bourliere M., Maynard-Muet M., Asselah T., Henrion J., Nevens F., Cassiman D., Geerts A., Moreno C., Beuers U.H., Galle P.R., Spengler U., Bugianesi E., Craxi A., Angelico M., Fargion S., Voiculescu M., Gheorghe L., Preotescu L., Caballeria J., Andrade R.J., Crespo J., Callera J.L., Ala A., Aithal G., Abouda G., Luketic V., Huang M.A., Gordon S., Pockros P., Poordad F., Shores N., Moehlen M.W., Bambha K., Clark V., Satapathy S., Parekh S., Reddy R.K., Sheikh M.Y., Szabo G., Vierling J., Foster T., Umpierrez G., Chang C., Box T., Gallegos-Orozco J.
Funder
European Community's Seventh Framework Programme Roche MSD Merck Gilead National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Gilead Sciences Taiwan J Pharma Tobira Immuron Galmed Arisaph Pharma Intercept Pharma Galactin BMS NGM Synageva Metabolon Genfit Taiwan J Hyperion Salix Abbvie Janssen GSK Vertex Novartis Genfit SA
Subject
Gastroenterology,Hepatology
Cited by
868 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|